PF-00446687 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Female Sexual Dysfunction
Conditions
Female Sexual Dysfunction
Trial Timeline
Jun 1, 2007 → Feb 1, 2008
NCT ID
NCT00479570About PF-00446687 + Placebo
PF-00446687 + Placebo is a phase 2 stage product being developed by Pfizer for Female Sexual Dysfunction. The current trial status is completed. This product is registered under clinical trial identifier NCT00479570. Target conditions include Female Sexual Dysfunction.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00479570 | Phase 2 | Completed |
Competing Products
20 competing products in Female Sexual Dysfunction